GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (NAS:BWAY) » Definitions » Shiller PE Ratio

BrainsWay (BrainsWay) Shiller PE Ratio : (As of Jun. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is BrainsWay Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BrainsWay Shiller PE Ratio Historical Data

The historical data trend for BrainsWay's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay Shiller PE Ratio Chart

BrainsWay Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BrainsWay Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BrainsWay's Shiller PE Ratio

For the Medical Devices subindustry, BrainsWay's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrainsWay's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BrainsWay's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BrainsWay's Shiller PE Ratio falls into.



BrainsWay Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BrainsWay's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, BrainsWay's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.007/131.7762*131.7762
=0.007

Current CPI (Mar. 2024) = 131.7762.

BrainsWay Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.117 100.560 -0.153
201409 -0.098 100.428 -0.129
201412 -0.453 99.070 -0.603
201503 -0.200 99.621 -0.265
201506 -0.100 100.684 -0.131
201509 -0.040 100.392 -0.053
201512 -0.220 99.792 -0.291
201603 -0.140 100.470 -0.184
201606 0.120 101.688 0.156
201609 -0.080 101.861 -0.103
201612 -0.220 101.863 -0.285
201703 -0.260 102.862 -0.333
201706 -0.060 103.349 -0.077
201709 -0.240 104.136 -0.304
201712 -0.380 104.011 -0.481
201803 -0.120 105.290 -0.150
201806 -0.240 106.317 -0.297
201809 -0.180 106.507 -0.223
201812 -0.280 105.998 -0.348
201903 -0.220 107.251 -0.270
201906 -0.340 108.070 -0.415
201909 -0.240 108.329 -0.292
201912 -0.200 108.420 -0.243
202003 -0.300 108.902 -0.363
202006 -0.060 108.767 -0.073
202009 -0.080 109.815 -0.096
202012 -0.040 109.897 -0.048
202103 -0.100 111.754 -0.118
202106 -0.120 114.631 -0.138
202109 -0.100 115.734 -0.114
202112 -0.080 117.630 -0.090
202203 -0.100 121.301 -0.109
202206 -0.140 125.017 -0.148
202209 -0.300 125.227 -0.316
202212 -0.240 125.222 -0.253
202303 -0.140 127.348 -0.145
202306 -0.100 128.729 -0.102
202309 -0.020 129.860 -0.020
202312 0.008 129.419 0.008
202403 0.007 131.776 0.007

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BrainsWay  (NAS:BWAY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BrainsWay Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of BrainsWay's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BrainsWay (BrainsWay) Business Description

Traded in Other Exchanges
Address
19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.